Changes to be introduced to Australian medicine labels

9 August 2016

The Australian government wants its new requirements over medicine labels to make important information about drugs easier to find.

Labeling requirements for Australian medicines have not been updated for many years, and the country’s Department of Health is acting to ensure that they clearly identify a particular drug and provide enough information to allow patients to make safe and informed decisions.

These changes will help to bring Australian medicine labels up to date and align them with international best practice, and are designed to make labels clearer and more consistent. They demand the inclusion of more information about any substances, such as allergens, that are contained in the medicine that could result in health problems in some people.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK